Drug Shortage Report for ARGATROBAN

Last updated on 2022-09-12 History
Report ID 169150
Drug Identification Number 02243835
Brand name ARGATROBAN
Common or Proper name ARGATROBAN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ARGATROBAN
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1LIVI
ATC code B01AE
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-11-01
Actual start date
Estimated end date 2023-03-31
Actual end date
Shortage status Anticipated shortage
Updated date 2022-09-12
Company comments Sandoz Canada is presently making all efforts to avoid or limit the shortage situation including the increase of inventory level of alternative antithrombotic agents and searching for an alternative foreign source of the equivalent product as interim solutions.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-09-12 French Compare
v1 2022-09-12 English Compare

Showing 1 to 2 of 2